PLCG2 and autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation: Interestingly, some of the somatic mutations in the resistant CLL are identical to genetic lesions found in APLAID and include mutations of PLCγ2 S707 and M1141 residues [6,15,32,33].